VX-264 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-03-12 in 4mo
ESTIMATED |
READOUT
A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1
Phase 1/2 · Type 1 Diabetes |
Vertex Pharmaceuticals Incorporate | VX-264 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-11-02
Sponsor-projected date — can change
|